Objective: To examine the influence of different performance validity test (PVT) cutoffs on neuropsychological performance, postconcussion symptoms, and rates of neurocognitive disorder and postconcussional syndrome following mild traumatic brain injury (MTBI) in active duty service members. Method: Participants were 164 service members (Age: M = 28.1 years [SD = 7.3]) evaluated on average 4.1 months (SD = 5.0) following injury. Participants were divided into three mutually exclusive groups using original and alternative cutoff scores on the Test of Memory Malingering (TOMM) and the Effort Index (EI) from the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): (a) PVT-Pass, n = 85; (b) Alternative PVT-Fail, n = 53; and (c) Original PVT-Fail, n = 26. Participants also completed the Neurobehavioral Symptom Inventory. Results: The PVT-Pass group performed better on cognitive testing and reported fewer symptoms than the two PVT-Fail groups. The Original PVT-Fail group performed more poorly on cognitive testing and reported more symptoms than the Alternative PVT-Fail group. Both PVT-Fail groups were more likely to meet DSM-5 Category A criteria for mild and major neurocognitive disorder and symptom reporting criteria for postconcussional syndrome than the PVT-Pass group. When alternative PVT cutoffs were used instead of original PVT cutoffs, the number of participants with valid data meeting cognitive testing criteria for neurocognitive disorder or postconcussional syndrome decreased dramatically. Conclusion: PVT performance is significantly and meaningfully related to overall neuropsychological outcome. By using only original cutoffs, clinicians and researchers may miss people with invalid performances.
Introduction
Traumatic brain injury (TBI) has been one of the most common injuries sustained by US military service members during the conflicts in Iraq and Afghanistan (Hoge et al., 2008; Terrio et al., 2009) , with the majority of these injuries (i.e., 85%; MacGregor et al., 2010) being classified as mild. Typically, symptoms improve and resolve within days, weeks, or months following a mild TBI (MTBI); however, for a small minority of people, non-specific symptoms and problems may persist long term (Carroll et al., 2014) . There are many reasons why a person might have chronic symptoms and problems following a MTBI, such as having co-occurring difficulties with traumatic stress (Boyle et al., 2014; Lagarde et al., 2014) and depression (Iverson et al., 2017; Solomon, Kuhn, & Zuckerman, 2016) , or involvement in compensation claims, such as worker's compensation, personal injury litigation, or disability determinations (Binder & Rohling, 1996; Iverson, Zasler, & Lange, 2006) . For people who do not recover in a timely manner, a comprehensive neuropsychological evaluation is recommended (McCrea et al., 2008) .
Assessment of performance validity (Larrabee, 2012) is considered standard practice when conducting neuropsychological evaluations of individuals who are involved in litigation or compensation-related evaluations. Formal evaluation of performance validity is considered an integral component of all neuropsychological evaluations and has been strongly supported in position papers by two prominent neuropsychological societies (Bush et al., 2005; Heilbronner, Sweet, Morgan, Larrabee, & Millis, 2009 ). Additionally, the Military TBI Task Force (McCrea et al., 2008) recommended that all neuropsychological assessment methods include performance validity tests (PVTs). It has been estimated that 17% (Whitney, Shepard, Williams, Davis, & Adams, 2009 ) to 58% (Armistead-Jehle, 2010) of veterans and service members presenting for neuropsychological evaluation fail PVTs. Typically, neuropsychological assessment in service members contributes to decision-making regarding whether they are fit for duty, are deployable, should be restricted from hazardous duty, and/or require a medical board evaluation or disability pension. These unique opportunities for secondary gain may explain the high rate of PVT failure in military populations. Indeed, rates of PVT failure vary significantly by evaluation context (Armistead-Jehle & Buican, 2012; Nelson et al., 2010; McCormick, Yoash-Gantz, McDonald, Campbell, & Tupler, 2013) .
There is substantial evidence that failure of PVTs is associated with low neuropsychological test scores (Constantinou, Bauer, Ashendorf, Fisher, & McCaffrey, 2005; Green, 2007; Green, Rohling, Lees-Haley, & Allen, 2001; Iverson, 2006; Stevens, Friedel, Mehren, & Merten, 2008; Lange, Pancholi, Bhagwat, Anderson-Barnes, & French, 2012) . PVT failure has also been associated with worse self-reported general functioning (Lippa, Pastorek, et al., 2014) , greater cognitive complaints (Armistead-Jehle, Gervais, & Green, 2012) , and greater post-concussive symptoms Kirkwood, Peterson, Connery, Baker, & Grubenhoff, 2014; Tsanadis et al., 2008) . Therefore, failure of PVTs is associated with greater symptoms, worse cognitive functioning, and greater disabilitybut the accuracy of those clinical outcome measures is uncertain.
One of the most widely used PVTs (Sharland & Gfeller, 2007) is the Test of Memory Malingering (TOMM; Tombaugh, 1996) . The TOMM manual specifies cutoffs for identifying response bias. However, more recent studies have suggested the use of higher cutoff scores on the TOMM in MTBI patients can increase its sensitivity to detect invalid performance while maintaining acceptable specificity (e.g., ≤48 on Trial 2; Greve, Bianchini, & Doane, 2006; Jones, 2013; Stenclik, Miele, Silk-Eglit, Lynch, & McCaffrey, 2013) . Moreover, several studies have used TOMM Trial 1 as an indicator of invalid performance in MTBI patients, with cutoff scores ranging from ≤38 to ≤42 (Bauer, O'Bryant, Lynch, McCaffrey, & Fisher, 2007; Denning, 2012; Greve et al., 2006; Jones, 2013; Stenclik et al., 2013) . Denning (2012) provides a summary of multiple studies that have investigated TOMM Trial 1 cutoffs, the weighted average of which was a cutoff of ≤40.
Administering formal stand-alone PVTs, such as the TOMM, typically takes 10-20 min (Strauss, Sherman, & Spreen, 2006) , which may reduce the amount of time available for administration of other neuropsychological tests. As such, there has been a recent focus on the development and validation of PVTs that are embedded into existing cognitive tests. One such embedded PVT is the Effort Index (EI; Silverberg, Wertheimer, & Fichtenberg, 2007) from the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS; Randolph, Tierney, Mohr, & Chase, 1998) . The RBANS EI has been used in a number of studies with service members and veterans (Jones, 2016; Lippa, Lange, Bhagwat, & French, 2017; Paulson, Horner, & Bachman, 2015; Zimmer, Heyanka, & Proctor-Weber, 2017) ; individuals with Parkinson's disease (Carter, Scott, Adams, & Linck, 2016) , schizophrenia (Moore et al., 2013; Morra, Gold, Sullivan, & Strauss, 2015) , Huntington's disease (Sieck, Smith, Duff, Paulsen, & Beglinger, 2013) , and dementia (Dunham, Shadi, Sofko, Denney, & Calloway, 2014; Morra et al., 2015) ; and in those involved in compensation-seeking disability evaluations (Crighton, Wygant, Holt, & Granacher, 2015) . The EI is calculated by creating a weighted composite score from performance on the Digit Span and List Recognition subtests. In their original study, Silverberg et al. (2007) concluded that an EI score >3 reflects invalid performance because it was rarely found in the general population. The authors also concluded that an EI score ≥1 is most sensitive with patients with post-acute MTBI when the goal is to determine if the performance is invalid. Other studies have supported the cutoff of >3 in geriatric (Barker, Horner, & Bachman, 2010; Hook, Marquine, & Hoelzle, 2009) and veteran samples (Barker et al., 2010; Young, Baughman, & Roper, 2012 ). An investigation of the two suggested cutoffs in an MTBI sample revealed that the ≥1 cutoff classified MTBI participants more accurately than the >3 cutoff (ArmisteadJehle & Hansen, 2011).
Although alternative PVT cutoffs have been supported for use with MTBI patients in the literature, these cutoffs do not yet appear to be widely adopted for use with this population. We have observed that many clinical neuropsychologists do not apply the newer, more sensitive, and slightly less specific PVT cutoffs with their MTBI patients. Recent MTBI research studies continue to define TOMM failure based on original, rather than alternative, cutoffs (Clark et al., 2016; Proto et al., 2014; Verfaellie, Lafleche, Spiro, & Bousquet, 2014) . This might be due in part to the emphasis on prioritizing specificity and positive predictive power over sensitivity and negative predictive power when it comes to the use of PVTs (Greve & Bianchini, 2004 .
Given the discrepancy between research supporting alternative PVT cutoffs following MTBI, and the continued use of original PVT cutoffs, the present study examined the influence of using original versus alternative PVT cutoffs in clinical decision-making. It was hypothesized that: (a) participants evaluated following an MTBI who failed PVTs based on original cutoffs would be most likely to meet cognitive testing criteria for Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) mild and major neurocognitive disorder and symptom reporting criteria for the International Classification of Diseases 10th edition (ICD-10) postconcussional syndrome (PCS); (b) participants who passed PVTs would be least likely to meet criteria for these diagnoses; and (c) participants who failed PVTs based on alternative cutoffs, but not based on original cutoffs, would meet criteria for these diagnoses more frequently than participants who passed PVTs, but less frequently than participants who failed PVTs based on original cutoffs.
Methods

Participants
Participants were 164 U.S. military service members who sustained an MTBI and were evaluated at the Walter Reed Army Medical Center (WRAMC), Washington, DC. Participants were selected from a larger sample of 313 military service members diagnosed with MTBI who were evaluated at WRAMC between November 2003 and January 2011 following a suspected or confirmed TBI, and who had agreed to the use of their clinical data for research purposes. The protocols under which these data were collected were approved by the Institutional Review Board of WRAMC. This study was completed in accordance with the guidelines of the Declaration of Helsinki.
All patients had been referred to the neuropsychology TBI service at WRAMC for consultation as a result of self-reported or clinician reported concern about their cognitive functioning. Patients were included in the original sample if they: (a) had sustained an MTBI, (b) were administered the RBANS, and (c) had not been administered the RBANS previously by the neuropsychology TBI service. Participants were excluded from the final sample if they were more than 2 years post-injury (n = 22), were missing time since injury data (n = 3), did not complete or had an incomplete Neurobehavioral Symptom Inventory (NSI; Cicerone & Karlmar, 1995, n = 23) , had incomplete RBANS data (n = 6), were not administered the TOMM (n = 53), or scored 45-48 on TOMM Trial 1 and were not administered TOMM Trial 2 (n = 46).
Participants were administered the RBANS, TOMM, and the NSI for the purposes of providing a brief screen of cognitive functioning and post-concussive symptoms. For the participants who scored 49 or 50 on TOMM Trial 1 (n = 79), TOMM Trial 2 was not administered, under the assumption that participants would score at least as well on Trial 2 as they did on Trial 1. Of 453 patients who scored 49-50 on TOMM Trial 1, only 2 (0.4%) scored 48 and none scored below 48 on Trial 2 (Mossman, Wygant, Gervais, & Hart, 2017) . No participants in the current study were administered the TOMM retention trial.
Mild TBI was defined as a period of self-reported loss of consciousness (LOC) ≤15 min, posttraumatic amnesia ≤24 h, and/or altered mental status ≤24 h following a credible injury mechanism. Although we would have preferred to use an LOC criterion of <30 min, consistent with commonly used diagnostic criteria (Carroll, Cassidy, Holm, Kraus, & Coronado, 2004 Group, 1993) , the available information regarding LOC was limited to categorical data that did not allow us to differentiate between duration of LOC greater than or less than 30 min (i.e., available data = LOC < 15 min and LOC 16-60 min). Glasgow Coma Scale scores were not available for most participants.
Participants were divided into three mutually exclusive groups based on their performance on the TOMM and RBANS EI. Participants were included in the Original PVT-Fail group if they failed either the RBANS EI with a score >3 (Barker et al., 2010; Hook et al., 2009; Young et al., 2012) or if TOMM Trial 2 was below the cutoff specified in the manual. They were included in the Alternative PVT-Fail group if they did not meet criteria for the Original PVT-Fail group and scored 1-3 on the RBANS EI (Armistead-Jehle & Hansen, 2011), ≤40 on TOMM Trial 1 (Denning, 2012) , or 45-48 on TOMM Trial 2 (Greve et al., 2006; Jones, 2013) . Participants were included in the PVT-Pass group if they scored >40 on TOMM Trial 1, >48 on TOMM Trial 2 (if administered), and 0 on the RBANS EI.
A total of 26 participants were included in the Original PVT-Fail group. Of these, 24 failed TOMM Trial 2 with a score <45 and 8 participants failed the RBANS EI with a score >3. A total of 53 participants were in the Alternative PVT-Fail group. Of these, 26 failed TOMM Trial 1 with a score ≤40, 22 failed TOMM Trial 2 with a score of 45-48, and 33 failed the RBANS EI with a score of 1-3. A total of 85 participants were in the PVT-Pass group.
Measures and Procedure
Neurocognitive Assessment and DSM-5 Category A Criteria for Mild and Major Neurocognitive Disorder
The RBANS (Randolph et al., 1998 ) is a battery of 12 subtests assessing 5 cognitive domains, including Immediate Memory/Learning, Visuospatial/Constructional, Language, Attention, and Delayed Memory. The RBANS was originally developed to screen for dementia, but has also been validated for use in patients following TBI (Lippa, Hawes, Jokic, & Caroselli, 2013; McKay, Casey, Wertheimer, & Fichtenberg, 2007; McKay, Wertheimer, Fichtenberg, & Casey, 2008; Pachet, 2007) . The DSM-5 Category A criteria for mild neurocognitive disorder indicates that a patient demonstrates performance ≥1SD below expectations in at least one cognitive domain (American Psychiatric Association, 2013). The DSM-5 Category A criteria for major neurocognitive disorder indicates that the patient demonstrates performance ≥2 SD below expectations in at least one cognitive domain. Importantly, a clinical diagnosis of mild or major neurocognitive disorder requires clinical judgment, and in the case of major neurocognitive disorder, evidence of reduced independence in daily activities. The present study defined mild neurocognitive disorder as present when at least two scores in a single cognitive domain were ≥1 SD below the mean. The cognitive domains of Immediate Memory, Visuospatial Functioning, Language, and Attention each consisted of only two subtests and therefore performance must have been ≥1 SD below the mean on both subtests in at least one domain for the participant to meet DSM-5 Category A criteria for mild neurocognitive disorder. For the Delayed Memory domain, participants must have been ≥1 SD below the mean on at least two of the following subtest: List Recall, Story Recall, or Figure Recall. Major neurocognitive disorder was defined as present when at least two performances in a single cognitive domain were ≥2 SD below the mean of the normative sample. We required two scores below the respective cutoffs because obtaining a single low score is fairly common in healthy adults (see Brooks, Iverson, and Holdnack (2013) for a detailed discussion).
Post-Concussive Symptoms and Postconcussional Syndrome
The NSI (Cicerone & Karlmar, 1995 ) is a 22-item questionnaire assessing post-concussive symptoms. Participants are asked to rate symptoms on a 5-point Likert scale ranging from 0 (none) to 4 (very severe). Each of the NSI symptoms was analyzed individually and a total score consisting of all 22 items was also computed.
Participants were classified into groups reflecting whether they endorsed symptoms reflective of PCS based on ICD-10 criteria. The ICD-10 criteria for PCS require a person to have a history of 'head trauma with a loss of consciousness' preceding the onset of symptoms by a period of up to 4 weeks and have symptoms in at least three of six categories: physical symptoms, emotional symptoms, cognitive symptoms, insomnia, reduced tolerance to alcohol, and preoccupation with the aforementioned symptoms and fear of permanent brain damage (World Health Organization, 1992) . For the present study, we did not require prior injuries to have a witnessed loss of consciousness. Additionally, because the NSI contains symptoms covering the physical, emotional, cognitive, and insomnia domains, but not the alcohol tolerance and preoccupation with symptoms/ brain damage domains, only the first four domains were evaluated. It is important to acknowledge that symptoms endorsed on the NSI should be evaluated clinically. Clinical diagnosis of PCS is multifaceted and requires a comprehensive evaluation (see Iverson and colleagues (2013) for a comprehensive discussion). For the purposes of this study, however, participants were classified as meeting symptom criteria for PCS if they endorsed at least one symptom in at least three of the four physical, emotional, cognitive, and insomnia domains as moderate (i.e., a score of 2 on a scale of 0-4) or greater on the NSI. Otherwise, participants' responses on the NSI were classified 'within normal limits.'
Statistical Analyses
Chi-square analysis and ANOVAs were used to compare the three participant groups in terms of demographic variables, self-reported post-concussive symptoms, cognitive test scores, and the base rates of meeting DSM-5 Category A criteria for mild and major neurocognitive disorder and ICD-10 criteria for PCS. SPSS (version 20) was used for all analyses. All analyses were conducted with p value <.01 to minimize Type I error.
Results
Demographics and Injury Characteristics
The majority of participants (95.1%) were men. Participants were an average of 28.1 (SD = 7.3) years old with an average of 13.0 (SD = 1.9) years of education. Participants identified themselves as Caucasian (76.2%), Hispanic (13.4%), African American (4.9%), or another race (3.0%; 2.4% did not report a race/ethnicity). Participants were assessed an average of 4.1 months (SD = 5.0; Range = 0-24 months) following injury. There were no significant main effects for age, education, gender, or ethnicity across the three PVT groups. Time since injury did significantly differ across the groups, F(1,161) = 3.306, p = .039. 
Neurocognitive Performance and Classification of Mild and Major Neurocognitive Disorder
Descriptive statistics, group comparisons, and effect sizes (Cohen, 1988) for the RBANS subtests and index scores by PVT group are presented in Table 1 . Data for the majority of the RBANS indices and individual subtests were not normally distributed; therefore, pair-wise comparisons using Mann-Whitney U tests were used. They indicated that both the Original PVT-Fail and Alternative PVT-Fail groups performed significantly worse on all RBANS indices compared to the PVT-Pass group. Participants in the Original PVT-Fail group performed worse than the Alternative PVT-Fail group on the Total Scale, Immediate Memory, and Delayed Memory Indices. Compared to the PVT-Pass group, the Original PVT-Fail group performed significantly worse on 11 of 12 individual subtests, with Figure Copy The percentage of participants that met DSM-5 Category A criteria for mild and major neurocognitive disorder, as well as the percentage of participants scoring one and two standard deviations below the mean of the normative sample on each of the RBANS indices, are presented in Table 2 . Chi-square tests with Yates Continuity Correction indicated that participants in the PVT-Pass group were significantly less likely than participants in the Alternative PVT-Fail group to meet cognitive testing criteria for mild neurocognitive disorder. (χ 2 (1, n = 138) = 22.38, p < .001) or major neurocognitive disorder (χ 2 (1, n = 138) = 15.20, p < .001). Participants in the PVT-Pass group were also significantly less likely than participants in the Original PVT-Fail group to meet cognitive testing criteria for mild neurocognitive disorder (χ 2 (1, n = 111) = 30.52, p < .001) or major neurocognitive disorder (χ 2 (1, n = 111) = 47.07, p < .001). The majority (84.6%) of the participants in the Original PVT-Fail group, 64.2% of participants in the Alternative PVT-Fail group, and 22.4% of participants in the PVT-Pass group met DSM-5 Category A criteria for mild neurocognitive disorder. Similarly, 57.7% of the Original PVTFail group and 22.6% of the Alternative PVT-Fail group, but only 1.2% of participants in the PVT-Pass group met DSM-5 Category A criteria for major neurocognitive disorder.
Additional analyses were conducted to evaluate how the proportion of participants meeting Category A criteria for mild and major neurocognitive disorder changed when alternative cutoffs were used instead of original cutoffs. As seen in Fig. 1 , when alternative cutoffs were used instead of original cutoffs, 34 fewer participants met DSM-5 Category A criteria for mild neurocognitive disorder, changing the percentage of participants meeting cognitive testing criteria for mild neurocognitive disorder from 32.3% to 11.6% and increasing the percentage of participants who failed PVTs from 15.9% to 48.2%. As shown in Table 2 , the Original PVT-Fail group was more likely than the PVT-Pass group to perform ≥2 SD below the standardization sample mean in each of the five cognitive domains. The Original PVT-Fail group was also more likely than the PVT-Pass group to perform ≥1 SD below the standardization sample mean in all cognitive domains except for Visuospatial Functioning. The Alternative PVT-Fail group was more likely than the PVT-Pass group to perform ≥1 SD below the standardization mean in the domains of Attention and Delayed Memory. Overall, the memory indices were most strongly related to PVT performance. No participants in the PVT-Pass group performed ≥2 SDs below the mean of the normative sample on the Immediate Memory Index, while 3.8% of participants in the Alternative PVT-Fail group and 30.8% of participants in the Original PVT-Fail group scored ≥2 SDs below the mean of the normative sample. On the Delayed Memory Index, 5.9% of participants in the PVT-Pass group, 41.5% of participants in the Alternative PVT-Fail group, and 76.9% of participants in the Original PVT-Fail group scored ≥1 SD below the standardization sample mean. Similarly, 1.2% of participants in the PVT-Pass group, 9.4% of participants in the Alternative PVT-Fail group, and 50.0% of participants in the Original PVTFail group scored ≥2 SD below the standardization sample mean on the Delayed Memory Index.
The number of cognitive domains with consistent low scores is displayed in Figs. 2 and 3 . Only 1.2% of participants in the PVT-Pass scored ≥1 SD below the standardization sample mean in three or more cognitive domains, whereas 11.3% of participants in the Alternative PVT-Fail group and 46.1% of participants in the Original PVT-Fail group had scores that consistently were ≥1 SD below the mean in three or more cognitive domains. Only 1.2% of participants in the PVT-Pass group scored ≥1 SD below the mean in one or more cognitive domains, compared to 22.7% of participants in the Alternative PVTFail group and 57.6% of participants in the Original PVT-Fail group.
Post-concussion Symptoms
Descriptive statistics, group comparisons, and Cohen's effect sizes (Cohen, 1988) for the 22 individual NSI symptoms and total score, by PVT group, are presented in Table 3 . Participants in both PVT-Fail groups had higher NSI total scores compared to those in the PVT-Pass group. Participants in the Original PVT-Fail group reported significantly greater symptom severity than participants in the PVT-Pass group for 20 of the 22 individual items, with the largest effect sizes found with symptoms relating to headaches, sensitivity to light, and depression (all ds ≥1.21).
Symptom endorsement rates were further compared with ICD-10 symptom reporting criteria for PCS. Chi-square analyses revealed significant differences between the groups; 65.4% of participants in the Original PVT-Fail group, 43.4% of participants in the Alternative PVT-Fail group, and 21. significantly less likely than participants in the Alternative PVT-Fail group and Original PVT-Fail group to meet ICD-10 symptom reporting criteria for PCS. When using original PVT criteria, 41 of the 136 participants who passed PVTs met symptom reporting criteria for PCS; however, when alternative PVT criteria were used, only 18 participants who passed PVTs met symptom reporting criteria for PCS.
Discussion
The current study illustrated a statistically significant and clinically meaningful relationship between PVT performance and the overall outcome from a neuropsychological evaluation. Participants who failed PVTs were more likely to meet ICD-10 symptom reporting criteria for PCS and DSM-5 Category A criteria for mild and major neurocognitive disorder. Participants who failed PVTs performed worse on most cognitive measures and reported worse PCS symptoms than participants who passed PVTs. The current study also found a PVT failure rate of 15.9% when using original cutoff scores; however, when using alternative cutoffs that have been validated in MTBI samples, the failure rate more than tripled to 48.2%. Additionally, when using alternative PVT cutoffs rather than original PVT cutoffs, the number of patients who passed PVTs and met DSM-5 Category A criteria for mild neurocognitive disorder dropped from 53 (32.3%) to 19 (11.6%) and the number of participants who passed PVTs and met cognitive testing criteria for major neurocognitive disorder dropped from 13 (7.9%) to 1 (0.6%). Use of alternative cutoffs also decreased the number of participants who passed PVTs and met criteria for PCS from 41 (24.4%) to 18 (10.7%).
Participants in both PVT failure groups performed significantly worse on cognitive measures and reported more severe post-concussion symptoms than participants who passed PVTs based on alternative cutoffs. Additionally, participants who failed PVTs based on original cutoffs also performed more poorly on many cognitive measures than participants who failed PVTs based on alternative cutoffs but not based on original cutoffs. These findings illustrate a gradient in the relationship between effort testing and clinical outcomes and supports past research that suggests performance validity lies on a continuum (Armistead-Jehle, Cooper, & Vanderploeg, 2016; Lippa, Agbayani, Hawes, Jokic, & Caroselli, 2014; Rogers, 2008; Walters, Berry, Rogers, Payne, & Granacher, 2009; Walters et al., 2008) . Notably, Armistead-Jehle et al. (2016) previously demonstrated that in active duty service members with a history of possible mild TBI who passed two formal PVTs, performance validity test scores explained the greatest amount of variance (6.6%) in neurocognitive performance. Patients who performed perfectly on both PVTs performed significantly better (medium to large effect sizes) on RBANS Immediate Memory, Visuospatial, Language, Delayed Memory, and Total Score Indices. These findings are similar to the current study's findings that found significantly better performance on all RBANS Indices (moderate to very large effect sizes) in patients who passed PVTs compared to patients who failed Alternative PVT cutoffs.
The most striking differences in cognitive performance between the groups were noted on the memory indices. Only 1.2% of participants who passed Alternative PVT cutoffs scored ≥2 SDs below the mean of the normative sample in the Delayed Memory domain, while 9.4% of participants who failed PVTs based on alternative cutoffs and 50.0% of participants who failed PVTs based on original cutoffs scored at least two SDs below the mean of the normative sample. No participants who passed PVTs based on alternative cutoffs scored ≥2 SDs below the mean of the normative sample on the Immediate Memory Index, while 3.8% of participants who failed PVTs based on alternative cutoffs and 30.8% of participants who failed PVTs based on original cutoffs scored ≥2 SDs below the mean.
A rather large number (22.4%) of participants who passed PVTs met the DSM-5 Category A criteria for mild neurocognitive disorder. Such a high rate of diagnosis in a healthy sample suggests that DSM-5 Category A criteria for mild neurocognitive disorder may be rather non-specific. The high rate of satisfying the DSM-5 Category A criteria for mild neurocognitive disorder in the present study could also be the result of several factors. First, this study was conducted with active duty service members, many of whom likely had comorbidities including depression, anxiety, PTSD, and chronic pain, which have all been shown to negatively affect cognitive performance (Drag, Spencer, Walker, Pangilinan, & Bieliauskas, 2012; Nicholson, Martelli, & Zasler, 2001; Vasterling et al., 2012; Verfaellie, Lafleche, Spiro, & Bousquet, 2014) . Secondly, 30 participants were tested within a month of their injury, when cognitive impairments are more likely. Thirdly, financial incentives have been shown to be strongly related to neuropsychological performance (Binder & Rohling, 1996) and many of these evaluations were conducted in the context of a disability evaluation. Finally, the participants were all aware they were undergoing an evaluation related to their TBI. Diagnosis threat could have affected these participants' performance, as this has been shown to negatively affect cognitive performance in MTBI patients (Blaine, Sullivan, & Edmed, 2013; Suhr & Gunstad, 2005) . Additionally, it is acknowledged that this study defined mild and major neurocognitive disorder only by cognitive test performance. If the clinical interview and assessment of activities of daily living had been considered, it is possible these rates would be lower.
The main limitation of the current study is that the RBANS EI, which was used to define both of the PVT failure groups, overlaps with the RBANS Digit Span and List Recognition subtests, as well as the Attention, Delayed Memory, and Total Scale Indices. We ultimately decided to keep these measures in our analyses, rather than removing or altering them, because they are all used clinically. It is important to note, however, that the differences between the groups on these measures may be artificially inflated. Additionally, because some participants were tested within a month of their injury, it is possible that they scored below the cutoff due to genuine cognitive sequelae and were therefore incorrectly identified as failing PVTs; the alternative cutoffs for the TOMM and RBANS EI used in this study have not been validated in mild TBI samples. Importantly, however, participants in the PVT-Fail groups were significantly further from their injury than participants in the PVT-Pass group. With most studies employing PVTs, it is possible that certain participants were misclassified, because PVT criteria are defined through a rather tautological method (Bigler, 2012) . This is largely due to the fact that patients putting forth invalid test performances will not volunteer for validity studies and therefore there is no way to be certain that the criterion is accurate (Williams, 2011) . Regardless of which cutoffs were used, there was a clear relationship between PVT failure and meeting the cognitive testing criteria for neurocognitive disorder and PCS diagnoses, suggesting that, even if the group classifications were not 100% accurate, the overall findings are valid.
In conclusion, the current study illustrated that active duty service members with a history of MTBI who perform poorly on PVT measures are much more likely to fulfill the DSM-5 Category A criteria for neurocognitive disorder or ICD-10 symptom criteria for postconcussional syndrome. Presumably, many of these diagnoses would be inaccurate due to inadequate effort on testing and symptom exaggeration. Similar to previous findings supporting the use of updated cutoffs for the TOMM and RBANS EI in patients with mild TBI, the present findings demonstrate that these alternative cutoffs identify many more cases of possible invalid responding than the original cutoffs. Future research should continue to investigate the alternative PVT cutoffs examined here with mild TBI patients in non-military and/or non-disability settings. Additionally, continued research should investigate additional alternative cutoffs for use with mild TBI patients. By using only original cutoffs, clinicians and researchers may be missing some people with invalid performances. As always, PVT failure should be viewed in a clinical context. That is, failure of PVTs is indicative of invalid test data. Attribution of etiology may be more difficult. Nonetheless, by taking test results at face value in one who fails PVTs, incorrect assumptions are likely to be made. Clinicians should consider adopting well-validated alternative PVT cutoffs for use with MTBI patients.
